Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Maximising cancer treatment and research through omics, data sharing, and open science

Share :

London Global Cancer Week 2022

13 - 18 Nov 2022
Published: 20 Dec 2022
Views: 40
Rating:
Save
Dr Simon Parker - Data protection co-ordinator at the German Human Genome-phenome Archive

Dr Simon Parker speaks to ecancer about how omics, data sharing, and open science are being used to enhance cancer treatments and research.

He also covers how these resources are used in lower-middle-income countries and expands to discuss the future in global data sharing.

Related Videos

Synthetic biology and precision medicine in blood and gynaecological cancers
Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...
Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )
21 Dec 2023
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )
17 Oct 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity...
Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in...
Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

An Error Occurred: Internal Server Error

Oops! An Error Occurred

The server returned a "500 Internal Server Error".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.